Cite
HARVARD Citation
Curtis, J. et al. (n.d.). AB0235 Effect of baseline disease activity on achieving sustained low disease activity in baricitinib phase 3 studies. Annals of the rheumatic diseases. pp. 1130-1131. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Curtis, J. et al. (n.d.). AB0235 Effect of baseline disease activity on achieving sustained low disease activity in baricitinib phase 3 studies. Annals of the rheumatic diseases. pp. 1130-1131. [Online].